Mariotti F, Sponchiado F, Lagi F, Moroni C, Paggi R, Kiros S
Infect Dis Rep. 2023; 15(6):758-765.
PMID: 38131881
PMC: 10742684.
DOI: 10.3390/idr15060068.
Jhajra S, Sharma A, Diwakar K, Gupta B, Tanti S
Sudan J Paediatr. 2023; 23(1):91-97.
PMID: 37663107
PMC: 10468639.
DOI: 10.24911/SJP.106-1636877693.
Purbey P, Roy K, Gupta S, Paul M
Mol Immunol. 2023; 156:111-126.
PMID: 36921486
PMC: 10009586.
DOI: 10.1016/j.molimm.2023.03.009.
Hurle R, Soria F, Contieri R, Avolio P, Mancon S, Lazzeri M
Cancers (Basel). 2023; 15(5).
PMID: 36900409
PMC: 10000457.
DOI: 10.3390/cancers15051618.
Wen J, Liu Q, Tang D, He J
J Clin Med. 2023; 12(3).
PMID: 36769802
PMC: 9917948.
DOI: 10.3390/jcm12031154.
BCG and SARS-CoV-2-What Have We Learned?.
Kulesza J, Kulesza E, Kozinski P, Karpik W, Broncel M, Fol M
Vaccines (Basel). 2022; 10(10).
PMID: 36298506
PMC: 9610589.
DOI: 10.3390/vaccines10101641.
Significance of PPD Test for the Relationship Between BCG Vaccine and COVID-19 in Patients on Kidney Transplant Waiting List.
Voyvoda B, Ozel S, Sengul E, Memik O
Transplant Proc. 2022; 54(10):2677-2679.
PMID: 36163085
PMC: 9444498.
DOI: 10.1016/j.transproceed.2022.08.016.
A Comprehensive Meta-Analysis of COVID-19 in Latin America.
Ashktorab H, Pizuorno A, Fierro N, Villagrana E, Solis M, Cardenas G
SOJ Microbiol Infect Dis. 2022; 8(1):1-11.
PMID: 35937158
PMC: 9355387.
DOI: 10.15226/sojmid/8/1/001108.
Fiction and Facts about BCG Imparting Trained Immunity against COVID-19.
Kaur G, Singh S, Nanda S, Zafar M, Malik J, Arshi M
Vaccines (Basel). 2022; 10(7).
PMID: 35891168
PMC: 9316941.
DOI: 10.3390/vaccines10071006.
COVID-19 and tuberculosis: the double whammy of respiratory pathogens.
Shariq M, Sheikh J, Quadir N, Sharma N, Hasnain S, Ehtesham N
Eur Respir Rev. 2022; 31(164).
PMID: 35418488
PMC: 9488123.
DOI: 10.1183/16000617.0264-2021.
A global survey in the developmental landscape of possible vaccination strategies for COVID-19.
Gasmi A, Srinath S, Dadar M, Pivina L, Menzel A, Benahmed A
Clin Immunol. 2022; 237:108958.
PMID: 35218966
PMC: 8865932.
DOI: 10.1016/j.clim.2022.108958.
Pharmacotherapeutic approach toward urological medications and vaccination during COVID-19: a narrative review.
Shafiekhani M, Dehghani A, Shahisavandi M, Nabavizadeh S, Kabiri M, Hassani A
Ther Adv Urol. 2021; 13:17562872211046794.
PMID: 34603508
PMC: 8481748.
DOI: 10.1177/17562872211046794.
Regional TMPRSS2 V197M Allele Frequencies Are Correlated with COVID-19 Case Fatality Rates.
Jeon S, Blazyte A, Yoon C, Ryu H, Jeon Y, Bhak Y
Mol Cells. 2021; 44(9):680-687.
PMID: 34588322
PMC: 8490206.
DOI: 10.14348/molcells.2021.2249.
Bacille Calmette-Guérin: An ophthalmic perspective.
Jain M, Vadboncoeur J, Garg S, Biswas J
Surv Ophthalmol. 2021; 67(2):307-320.
PMID: 34343536
PMC: 8325561.
DOI: 10.1016/j.survophthal.2021.07.005.
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer.
Galsky M, Balar A, Black P, Campbell M, Dykstra G, Grivas P
J Immunother Cancer. 2021; 9(7).
PMID: 34266883
PMC: 8286774.
DOI: 10.1136/jitc-2021-002552.
SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective.
Naidoo P, Ghazi T, Chuturgoon A, Naidoo R, Ramsuran V, Mpaka-Mbatha M
Environ Int. 2021; 156:106695.
PMID: 34171587
PMC: 8205275.
DOI: 10.1016/j.envint.2021.106695.
Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19.
Inoue K, Kashima S
PLoS One. 2021; 16(6):e0253169.
PMID: 34143810
PMC: 8213125.
DOI: 10.1371/journal.pone.0253169.
Variances in BCG protection against COVID-19 mortality: A global assessment.
Sarfraz Z, Sarfraz A, Pandav K, Makkar S, Siddiqui S, Patel G
J Clin Tuberc Other Mycobact Dis. 2021; 24:100249.
PMID: 34124396
PMC: 8179855.
DOI: 10.1016/j.jctube.2021.100249.
Childhood Bacille Calmette-Guerin Vaccination and Its Association With Less Severe COVID-19 Pneumonia.
Chen F, Chen G, Zhou J, Xue Y, Wu M
Am J Prev Med. 2021; 61(3):e119-e126.
PMID: 33985834
PMC: 8041236.
DOI: 10.1016/j.amepre.2021.02.025.
Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update.
Mba I, Sharndama H, Osondu-Chuka G, Okeke O
Infect Dis (Lond). 2021; 53(8):559-580.
PMID: 33905282
PMC: 8095391.
DOI: 10.1080/23744235.2021.1916071.
